Neurohormones in mitral stenosis before and after percutaneous balloon mitral valvotomy

Journal of Heart Valve Disease

Volumn 11, Issue 2, 2002, Pages 185-190

  Razzolini, Renato ^a   Leoni, Loira ^a   Cafiero, Francesca ^a   Liva, Silvia ^a   Faggian, Diego ^a   Ramondo, Angelo ^a   Chioin, Raffaello ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROHORMONE; RENIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART INDEX; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE STENOSIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SUPINE POSITION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ADOLESCENT; BALLOON DILATATION; BLOOD; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; EVALUATION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; BALLOON DILATATION; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NEUROTRANSMITTER AGENTS; RENIN; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0036513796     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ledoux S, Dussaule JG, Mighel PL, Vahanian A, Wolf JP, Agar J, Ardaillou R. Acute and delayed hormonal changes in mitral stenosis treated by balloon valvulotomy. Am. J Cardiol 1993;72:932-938
2. Mangieri E, Tosti Croge C, Tanzilu G, et al. Short-term and 24-hour changes of atrial natriuretic factor, plasma levels after percutaneous transvenous mitral valvuloplasty. Hemodynamic and echocardiographic correlation. G Ital Cardiol 1993;23:1115-1123
3. Tsai RC, Yamaji T, Ishibashi M, et al. Atrial natriuretic peptide and vasopressin during percutaneous transvenous mitral valvuloplasty and relation to renin-angiotensin-aldosterone system and renal function. Am J Cardiol 1990;65:882-886
4. Mangieri E, Tosti Croge C, Ferraironi A, et al. Relationship between captopril and atrial natriuretic factor: An acute hemodynamic study. Cardiologia 1991;36:295-298
5. Fifer MA, Grossman W. Measurements of ventricular volume, ejection fraction, mass wall stress and regional wall motion. In: Bairn D, Grossman W (ed.). Cardiac Catheterization, Angiography and Intervention. Williams & Wilkins 1991:315-332
6. Trovato M, Carpinteri G. Atrial fibrillation effect on ANP secretion in congestive heart failure. Rec Prog Medicina 1994;85:570-575
7. Raine AEG, Erne P, Burgiser E, Muller FB, Boll P, Burkart F, Buhler F. Atrial natriuretic peptide and atrial pressure with congestive heart failure. N Engl J Med 1986;315:533-537
8. La Vecchia L, Fortunato A, Varotto L, Bonanno C, Paccanaro M, Ometto R, Vincenzi M. Hemodynamic correlates of atrial natriuretic peptide concentration in unselected patients with heart disease of different etiologies. G Ital Cardiol 1998;28:1363-1371
9. Fontana F, Spagnolo N, Capelli M, Bernardi P. Atrial natriuretic factor in acute atrial hyperkinetic arrhythmia and chronic atrial flutter-fibrillation. G Ital Cardiol 1989;19:417-427
10. Dussaule JC, Vahanian A, Michel PL, Soullier I, Czekalski S, Acar J, Ardaillou R. Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Circulation 1988;78:276-285
11. Seino Y, Shimai S, Ibuki C, Itoh K, Takano T, Haykawa H. Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: Endocrinologic silence. J Am Coll Cardiol 1991;18:459-463
12. Van Der Berg MP, Vanveldhuisen CJ, Van Gelder IC, De Kam PJ, Lie KI. Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: Role of duration of atrial fibrillation. Am Heart J 1998;135:242-244
13. Fujiwara H, Ishikura F, Nagata S, Beppu S, Miyatake K. Plasma atrial natriuretic peptide response to direct current cardioversion of atrial fibrillation in patients with mitral stenosis. J Am Coll Cardiol 1993;22:575-580
14. Sanfilippo A, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, Weyman AE. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990;82:792-797
15. Waldman H, Palacios I, Block P, et al. Responsiveness of plasma atrial natriuretic factor to short-term changes in left atrial hemodynamics after percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol 1988;12:649-655
16. Volpe M. The physiological role of atrial natriuretic factor. Cardioscience 1992;3:217-225
17. Suarez De Lezo J, Montilla P, Pan M, et al. Abrupt homeostatic responses to transient intracardiac occlusion during balloon valvuloplasty. Am J Cardiol 1989;64:491-497
18. Wolf JP, Dussaule JC, Vahnian A, Mighel PL, Agar J, Ardaillou R. Atrial natriuretic peptide response to postural changes in patients with left atrial hypertension. Eur Heart J 1990;11:1065-1073
19. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000;101:2612-2617